Drug candidates developed by Korean biotech companies such as Alteogen and LegoChem Biosciences have recently achieved milestones in licensing agreements.Alteogen said on Monday it obtained a milestone of $13 million from its technology transfer partner.The milestone is based on the entry of an agen
Celltrion said it presented the 24-week results from its global phase 3 clinical trial of CT-P42, a biosimilar referencing Eylea (ingredient: aflibercept).Eylea is a blockbuster ophthalmic drug developed by Regeneron and treats wet age-related macular degeneration (wAMD) and diabetic macular edema (
Lotte Biologics said it signed a memorandum of understanding (MOU) with Excellgene, a Swiss-based cell line development company, to collaborate on the CDO (contract development organization) business.Lotte Biologics said the MOU was part of its plan to promote its CDO business by attracting customer
A recent study conducted by Severance Hospital showed improved survival in colorectal cancer patients with increased muscle mass without BMI loss compared to those with steady muscle mass and BMI.Lifestyle habits such as diet and exercise have a great influence on the prognosis of cancer treatment.
Researchers at the Institute for Basic Science (IBS) have discovered a way to map the cerebral cortex activity of living mice to study brain circuits using a beam projector as optogenetic stimulation combined with functional magnetic resonance imaging (fMRI).fMRI scans the activity of the entire bra
Celltrion Group Chairman Seo Jung-jin announced that the company might look into building a new manufacturing facility in the U.S., in line with U.S. President Joe Biden's recent executive order to bolster U.S.-based biomanufacturing."We are keeping a close eye on the Biden executive order," Seo sai
Celltrion's shareholders' meeting on Tuesday started out rough, with angry shareholders shouting for Celltrion Vice Chairman Kee Woo-sung's resignation.The stock prices of the three affiliates have been on a downward trend since reaching their highest on Dec. 30, 2020.Celltrion was trading at 155,00
Elevar Therapeutics, the U.S. subsidiary of HLB, said Monday that it has participated in Bio Europe Spring in Basel, Switzerland, from March 20-22.Bio Europe Spring is the largest bio conference in Europe attended by global biopharmaceutical companies and investors. Global big pharma, such as Nova N
CJ Bioscience has introduced many microbiome-based new drug candidate substances, drawing the industry’s attention. CJ Bioscience is an independent company in the CJ Group’s Red Bio (pharmaceutical and healthcare) business division.CJ Bioscience announced Monday that it had signed a contract to take
Researchers at the National Cancer Center (NCC) have identified new bile duct cancer subtypes by analyzing proteogenomic data to reveal new therapeutic targets for intractable intrahepatic bile duct cancer, the hospital said.Protein genome research is in the spotlight as a research method that can o
SK Plasma said it will begin the construction of its new blood product plant in Indonesia, which will be able to manufacture a million liters of plasma raw materials annually, in May.The company plans to complete the construction by 2025.The announcement follows the Indonesian authorities approving
Juvic, a microneedle drug developer, said on Friday that it has successfully developed a new patch-type diabetes treatment called an egg microneedle (EMN) to overcome the limitations of existing dissolvable microneedles (DMN).The research team led by Professors Jung Hyung-il of the Biotechnology Dep
Tertiary hospitals in Korea and clinics have invested a lot in IT systems to enhance the convenience and quality of medical services but individuals still lack access to managing their own health, noted Kakao Healthcare CEO Hwang Hee.Kakao, known for its strength as a tech company, will focus on mob
Medical Korea 2023 kicked off on Thursday designating Super Junior’s Kim Ryeowook as the Medical Charity Honorary Ambassador to promote Korea’s medical tourism at COEX.“I am honoured to get this appointment to spread this cause and raise awareness of Koreas medical services,” said Kim of the K-pop i
Researchers at the Institute of Basic Sciences (IBS) have successfully mapped blood and lymph vessels in the nasal cavity in three dimensions for the first time in the world, revealing key observations for improving mucosal immunity.The nose is both a sensory organ responsible for smell and the firs
Celltrion and Thermo Fisher are reportedly vying to acquire the biopharma solutions unit of Baxter International.According to Reuters, the sale could go up as high as $4 billion, which would help alleviate Baxter's debt burden. Baxter's debt is considerably high at $16.6 billion as of the end of Dec
Researchers at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) developed a bacterial cancer therapeutic that increases drug permeability in cancerous tissues when combined with chemotherapeutic drugs.Chemotherapy stops the growth of cancer cells which can be administered orally,
CHA University Bundang Medical Center (CBMC) said on Monday that its researchers proved the safety and effectiveness of dopamine neural precursor cells derived from fetal mesenchymal stem cells transplanted into patients with Parkinson's disease "for the first time in the world."Parkinson's disease
Following the Moon Jae-in government, the Yoon Suk Yeol administration also emphasizes the need to promote the bio-industry. Still, there is a shortage of workers who jump into this field, experts pointed out Friday.That and other issues were discussed during the “5th K-Life & Bio Forum” held at the
Samsung Biologics held a board of directors meeting on Friday and announced that it will invest 1.9 trillion won ($1.45 billion) to build Plant 5, its fifth biopharmaceutical contract manufacturing organization (CMO) plant in Songdo, Incheon.Plant 5 will be the first plant in Bio Campus 2 and will b